Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Japfa Comfeed Indonesia Tbk. (JPFA) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Japfa Comfeed Indonesia Tbk.Trade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Japfa Comfeed Indonesia Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Japfa Comfeed Indonesia Tbk. trades at Rp2,030 (market cap 23.8T, 8.44M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp148 (market cap 576.7B, 3.48M 24h volume). The key difference: Japfa Comfeed Indonesia Tbk. is far larger — about 41.3× UBC Medical Indonesia Tbk.'s market cap, and Japfa Comfeed Indonesia Tbk. is more actively traded (8.44M versus 3.48M). Which is the better fit depends on your goals.

JPFALABS
Market Cap
23.8T576.7B
Volume
8.44M3.48M
Lot
84.36K34.82K
Turnover
17.08B522.79M
Average Price
2,024.41150.13
Value
17.08B522.79M
Indicative Equilibrium Price
2,030148
Indicative Equilibrium Volume
3.58K350

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

JPFA
View details
LABS
View details

About Japfa Comfeed Indonesia Tbk.

PT Japfa Comfeed Indonesia Tbk (the Company) was established within the framework of the Foreign Capital Investment Law No. 1 year 1967 based on Notarial Deed No. 59 dated January 18, 1971 of Djojo Muljadi, S.H., public notary, as amended by Notarial Deed No. 60 dated Februari 15, 1972, of the same notary. Japfa is currently the second largest animal feed producer in Indonesia with an estimated market share of around 35% in the domestic poultry feed market. The company was originally involved in the production of copra extraction pellets

Read more on JPFA

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS